Eyeworld

EW ASCRS•ASOA 2017 56 ASCRS•ASOA Program Preview • May 5–9, 2017 rectomy and PARS Plans Endoscopic Cyclophotocoagulation in Refrac- tory Glaucoma," "Safety of Novel Glaucoma Surgery and the Imme- diate Postoperative Period in Stand Along and Combined Phacoemulsifi- cation & CO2 Laser-Assisted Sclerec- tomy Surgery—CLASS," "Two-Year Treatment Outcomes in the Shunt Tube Exposure Prevention Study (STEPS)," and "Fractal Analysis of Optical Coherence Tomography Angiography in Primary Open-Angle Glaucoma." Monday, May 8 "MIGS, Trabeculectomy, and Goniotomy," a paper session from 8:00–9:30 a.m., will address "Out- come of Trabeculectomy With MMC and Both Releasable/Controllable Suture in Management of Advanced Glaucoma," "Outcomes of Using a Single-Handed Trabeculotome for Surgical Goniotomy for Treatment of Glaucoma," and "Excimer Laser Trabeculostomy a MIGS Procedure that Uses No Implants, and Lowers Intraocular Pressure Over 8 Years, Both Alone and With Phaco," to name a few. Also from 8:00–9:30 a.m. will be an instructional course on "Coexist- ing Cataract and Glaucoma: Tips for the Uneasy Relationship." Instruc- tors for this course are Ahmad Khalil, MD, PhD, Giza, Egypt, Alan Crandall, MD, Salt Lake City, Amar Agarwal, FRCS, Chennai, India, and Boris Malyugin, MD, PhD, Moscow, Russia. From 10:00–11:30 a.m., Reay H. Brown, MD, Atlanta, will present the Charles D. Kelman Innovator's Lecture entitled "Overcoming Resis- tance: Making Glaucoma a Surgical Disease." Later in the day from 3:00–4:30 p.m., an instructional course for those getting started with MIGS— pearls for using trabecular microby- pass stents—will be instructed by Carlos Buznego, MD, Miami. Tuesday, May 9 A course reviewing new technologies and devices presented in Russian will be hosted from 9:30–11:00 a.m. U.S. ophthalmologists will talk about technologies and devices with slides translated into Russian. Elena Vialova, MD, Baltimore, will serve as the instructor. EW by Liz Hillman EyeWorld Staff Writer cussed, as well as outcomes through 42 months following MIGS with two trabecular bypass stents in patients not controlled on one medication. Other research will include "Nine- Month Duration of Single Use Low- Dose Extended Release Travoprost and Matched IOP-Lowering Effects of Pre-Study Prostaglandin Analogs and In-Study Timolol," "Evaluation of Anterior Segment Parameters by Pentacam Imaging After Prophy- lactic Laser Peripheral Iridotomy," and "The Missed Glaucoma, a Case Series on Advanced Late Diagnosed Juvenile Glaucoma." From 1:00–2:30 p.m., Nir Sho- ham-Hazon, MD, Herzliya, Israel, and Shakeel Shareef, MD, Roches- ter, New York, will lead the course "Minimally Invasive Glaucoma Surgery for the Comprehensive Oph- thalmologist: Exploring Various Mi- crostents and Devices." The course will include a didactic portion as well as a skills transfer portion that will include intraoperative gonios- copy instruction and a look at four MIGS devices. Following from 3:00–4:30 p.m. will be a paper session on cyclopho- tocoagulation, CO2 laser, and glau- coma surgery. Papers include "Vit- Postoperative Period Observations of Supraciliary Microstent Implan- tation for IOP Control in Combined POAG-Cataract Surgery," and "Ab Externo Sibs Micro-Shunt with MMC Efficacy and Safety: Consecu- tive Prospective Interventional Case Series." An instructional course from 3:00–4:30 p.m. will provide in- formation about the indications, approaches, and techniques for using microstents and microinvasive devices. Iqbal "Ike" Ahmed, MD, Toronto, Canada, is the instructor of this course with, Douglas Rhee, MD, Cleveland, Richard Lewis, MD, Sacramento, California, Thomas Samuelson, MD, Minneapolis, Minnesota, Arsham Sheybani, MD, St. Louis, and Steven Vold, MD, Fayetteville, Arkansas, serving on the faculty. Sunday, May 7 Sunday's glaucoma offerings start with a paper session from 8:00–9:30 a.m. focused on MIGS. Four-year outcomes of MIGS with two trabecu- lar micro-bypass stents and postop- erative prostaglandin for open-angle glaucoma patients on two medica- tions preoperatively will be dis- MIGS and more I n addition to a full day of pro- graming at ASCRS' Glaucoma Day (see page 48 of this issue for more) Friday, May 5, in Los Angeles, ASCRS general sessions feature glaucoma offerings—sympo- sia, courses, and free paper ses- sions—as well. Microinvasive glaucoma surgery (MIGS) is a large focus of this year's programming with presentations not only covering the different op- tions but providing diagnostic tips and surgical pearls. Saturday, May 6 A paper session from 1:00–2:30 p.m. will cover some of the latest research involving MIGS and canaloplasty. Papers include "Efficacy of a New Ab Interno Gel Stent Alone Versus Gel Stent Combined with Phacoemulsi- fication for Glaucoma Treatment," "Long-Term, Single-Site Outcomes of Trabecular Bypass Stent and Cata- ract Surgery in Eyes with Previous Medical and/or Surgical Glaucoma Therapy," "Twelve-Month Outcomes of Ab-Interno Canaloplasty for Mild-to-Moderate Controlled and Uncontrolled Glaucoma," "Early April 2017 Must-see glaucoma sessions Attendees at the 2016 ASCRS•ASOA Symposium & Congress in New Orleans Source: ASCRS

• Blank Page
• Blank Page (1)